All Stories
Follow
Subscribe to Eckert & Ziegler Strahlen und Medizintechnik AG

Eckert & Ziegler Strahlen und Medizintechnik AG

ots Ad hoc-Service: Eckert & Ziegler AG <DE0005659700> Eckert & Ziegler Annual Financial Statements Show Record Results

Berlin (ots Ad hoc-Service) -

The sender is solely responsible for the contents of this
announcement.
Eckert & Ziegler Strahlen- und
Medizintechnik AG, a leading manufacturer of low-level radioactive
sources of radiation for medical and industrial applications, has
grown well above average during the 1999 fiscal year in comparison to
the prior year. As the company reported at ist balance sheet press
conference, revenues reached EUR 9.9 million (EUR 1.7 million,
+482%). The results for its ordinary operations rose to EUR 1.2
million (EUR 0.04 million, +3061%). The DVFA/SG results after taxes
increased to EUR 0.3 million (EUR -0.01 million). The DVFA/SG
earnings per share amounted to EUR 0.11 (EUR -0.005). At the same
time, the cash flow improved to EUR 2.5 million (EUR 1.6 million,
+60%).
The reason for this exceptional development is the continued
strong demand for low-level radioactive components for therapeutic
purposes, above all for the treatment of coronary disorders and
prostate cancer. "Among other factors, this demand stems from
demographic developments and an improved level of early diagnosis",
explains CEO Dr. Andreas Eckert.
Eckert & Ziegler AG will be announcing all its figures during
today's balance sheet press conference.
The Board of Directors
For further information please contact: Dr. Andreas Eckert CEO and
President Eckert & Ziegler AG Robert-Rössle-Str. 10 D-13125 Berlin
Tel.: (+ 49 30) 94 10 84 - 0 Fax: (+ 49 30) 94 10 84 - 112
End
Internet: http://recherche.newsaktuell.de

Original content of: Eckert & Ziegler Strahlen und Medizintechnik AG, transmitted by news aktuell

More stories: Eckert & Ziegler Strahlen und Medizintechnik AG
More stories: Eckert & Ziegler Strahlen und Medizintechnik AG